在化疗引起的脱发症中使用头皮冷却疗法:解决冷却持续时间和疗效的变化
Lily Kaufman1, Lilia Valentic1, Lauren Malley1
1College of Medicine, The Ohio State University, Columbus, OH, USA.
概括
头皮冷却疗法 (SCT) 可以减少化疗引起的脱发症 (CIA). 通过标准化冷却时间和探索创新来优化SCT协议对于更广泛的实施和患者满意度至关重要.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 患者护理 患者护理
背景情况:
- 化疗诱导的脱发症 (CIA) 显著影响癌症患者的心理社会福祉.
- 头皮冷却疗法 (SCT) 是一种缓解CIA的干预措施,但其有效性受到不一致的协议的限制.
研究的目的:
- 审查目前的SCT实践,用于CIA的预防.
- 确定导致SCT协议变化的因素.
- 探索优化SCT实施的战略.
主要方法:
- 关于SCT疗法的有效性,持续时间,患者因素和机构障碍的出版文献的叙事综述.
- 评估创新,以提高SCT可行性和减少椅子时间.
主要成果:
- 在SCT的研究中,使用分类剂方案的成功率高于使用人类循环剂.
- 冷却持续时间差异很大 (冷却前: 5-30 分钟;冷却后: 15 分钟-4 小时),对更长的持续时间的证据有限.
- 患者因素,员工的可用性和设备影响SCT的交付;便携式系统可以改善工作流程.
结论:
- 基于证据的SCT冷却持续时间的标准化对于改善访问,满意度和效率至关重要.
- 需要对缩短的协议,便携式系统和辅助疗法的进一步研究.
- 优化SCT协议可以提高其可行性和有效性,在管理CIA.
相关概念视频
Decreased Body Temperature
987
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
987
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


